Literature DB >> 9507037

Complement system in healthy term newborns: reference values in umbilical cord blood.

J Sonntag1, U Brandenburg, D Polzehl, E Strauss, M Vogel, J W Dudenhausen, M Obladen.   

Abstract

Activation of the complement system occurs in several diseases. For reliable identification of complement activation in neonates, we establish reference ranges of several components in cord blood of healthy term newborns. For this study, cord blood samples were taken from 125 healthy term newborns. Concentrations of C1r, C2, C5, C7, Properdin, and factors D, H, and I were determined by single radial immunodiffusion. C3a and C5a were measured by specific EIA and complement function was measured by hemolytic assays. The results were expressed as 5th percentile, median, and 95th percentile. The following respective concentrations were found: C1r: 27, 47, 65 mg/l; C2: 12.0, 18.0, 24.0 mg/l; C5: 64, 92, 127 mg/l; C7: 32, 60, 89 mg/l; Properdin: 5.6, 9.7, 14.2 mg/l; factor D: 3.6, 5.2, 7.3 mg/l; factor H: 178, 234, 296 mg/l; and factor I: 15, 24, 32 mg/l. The functional activity of the whole complement system was 24%, 43%, 97% and for the alternative pathway 39%, 58%, 76%. The concentration of the activated split products C3a was 4, 65, 255 microg/l and of C5a, 0.11, 0.26, 1.19 microg/l. These reference values may be important for the detection of deficiencies of native complement proteins or perinatal processes leading to an activation of the complement system.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9507037     DOI: 10.1007/s100249900016

Source DB:  PubMed          Journal:  Pediatr Dev Pathol        ISSN: 1093-5266


  13 in total

1.  Perinatal asphyxia may present with features of neonatal atypical hemolytic uremic syndrome.

Authors:  Valérie Biran; Sébastien Fau; Taleb Jamal; Frédérique Veinberg; Sylvain Renolleau; Francis Gold; Albert Bensman; Tim Ulinski
Journal:  Pediatr Nephrol       Date:  2007-08-03       Impact factor: 3.714

2.  Evidence for complement activation in the amniotic fluid of women with spontaneous preterm labor and intra-amniotic infection.

Authors:  Eleazar Soto; Roberto Romero; Karina Richani; Bo H Yoon; Tinnakorn Chaiworapongsa; Edi Vaisbuch; Pooja Mittal; Offer Erez; Francesca Gotsch; Moshe Mazor; Juan P Kusanovic
Journal:  J Matern Fetal Neonatal Med       Date:  2009-11

3.  Humanized mice, a new model to study the influence of drug treatment on neonatal sepsis.

Authors:  Wolfgang Ernst; Nicole Zimara; Frank Hanses; Daniela N Männel; Birgit Seelbach-Göbel; Anja K Wege
Journal:  Infect Immun       Date:  2013-02-25       Impact factor: 3.441

4.  Variation of Complement Protein Levels in Maternal Plasma and Umbilical Cord Blood during Normal Pregnancy: An Observational Study.

Authors:  Muna Saleh; Michele Compagno; Sofia Pihl; Helena Strevens; Barbro Persson; Jonas Wetterö; Bo Nilsson; Christopher Sjöwall
Journal:  J Clin Med       Date:  2022-06-22       Impact factor: 4.964

5.  Fragment Bb in amniotic fluid: evidence for complement activation by the alternative pathway in women with intra-amniotic infection/inflammation.

Authors:  Edi Vaisbuch; Roberto Romero; Offer Erez; Shali Mazaki-Tovi; Juan Pedro Kusanovic; Kusanovic Juan Pedro; Eleazar Soto; Francesca Gotsch; Zhong Dong; Tinnakorn Chaiworapongsa; Sun Kwon Kim; Pooja Mittal; Percy Pacora; Lami Yeo; Sonia S Hassan
Journal:  J Matern Fetal Neonatal Med       Date:  2009-10

6.  Genetic and environmental factors influencing the human factor H plasma levels.

Authors:  Jorge Esparza-Gordillo; José Manuel Soria; Alfonso Buil; Laura Almasy; John Blangero; Jordi Fontcuberta; Santiago Rodríguez de Córdoba
Journal:  Immunogenetics       Date:  2004-04-30       Impact factor: 2.846

Review 7.  Factors of the lectin pathway of complement activation and their clinical associations in neonates.

Authors:  Maciej Cedzynski; Anna St Swierzko; David C Kilpatrick
Journal:  J Biomed Biotechnol       Date:  2012-03-22

Review 8.  Dysfunction of innate immunity and associated pathology in neonates.

Authors:  Anna Petrova; Rajeev Mehta
Journal:  Indian J Pediatr       Date:  2007-02       Impact factor: 5.319

9.  In-vitro activation of complement system by lactic acidosis in newborn and adults.

Authors:  F Hecke; T Hoehn; E Strauss; M Obladen; J Sonntag
Journal:  Mediators Inflamm       Date:  2001-02       Impact factor: 4.711

10.  Complement activation by in vivo neonatal and in vitro extracorporeal membrane oxygenation.

Authors:  Johannes Graulich; Joseph Sonntag; Monika Marcinkowski; Karl Bauer; Hans Kössel; Christoph Bührer; Michael Obladen; Hans T Versmold
Journal:  Mediators Inflamm       Date:  2002-04       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.